Dr. John Millichap is next up in our Meet the Experts series.
He is a Pediatric Epileptologist in the Comprehensive Epilepsy Center, Ann & Robert H. Lurie Children’s Hospital of Chicago, and Assistant Professor of Pediatrics and Neurology at Northwestern University Feinberg School of Medicine. He completed residency in pediatrics at the Brody School of Medicine at East Carolina University, residency in Child Neurology, and fellowship in Clinical Neurophysiology / Pediatric Epilepsy at Children’s Memorial Hospital (now known as Lurie Children’s) and Northwestern University Feinberg School of Medicine.
Jack is very fortunate to have Dr. Millichap caring for him as a patient, and we are privileged to have his tireless help as the medical adviser to the Jack Pribaz Foundation.
[dropcap]Q.[/dropcap]How did you first get interested in studying epilepsy and the KCNQ2 mutation?
[dropcap]A.[/dropcap] I developed my subspecialty interest in the evaluation and treatment of epilepsy during my Child Neurology training in Chicago under the mentorship of Douglas Nordli, MD, the head of the Epilepsy Center at Lurie Children’s. After the first patient with KCNQ2 encephalopathy was diagnosed at Lurie Children’s, his parents contacted Dr Ed Cooper at Baylor School of Medicine, who has provided support and mentorship for my research in this field.
[dropcap]Q.[/dropcap] What are the biggest challenges you face in your work?
[dropcap]A.[/dropcap]One of the main goals of epilepsy treatment is to achieve no seizures, without side effects. Knowing the cause of the seizures is not only important for choosing the right treatments, but also for parents’ peace of mind and to end the need for continued testing.
[dropcap]Q.[/dropcap] What inspires or drives you as a researcher of genetic epilepsies?
[dropcap]A.[/dropcap]Caring for treatment-resistant epilepsy is a challenge. I am hopeful that improvements in genetic testing methods and the increase in knowledge about the causes of epilepsy will improve the lives of children with epilepsy.